12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's after-market session, health care stocks saw significant movements. Avalo Therapeutics (AVTX) led the gainers with a 215.8% increase to $15.0, while Strata Skin Sciences (SSKN) led the losers with a 12.5% decrease to $0.39. Other notable movers included Fresh2 Group (FRES), Biora Therapeutics (BIOR), and GlycoMimetics (GLYC), with their stock prices also experiencing changes due to various factors including Q4 earnings reports.
March 27, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
GlycoMimetics stock fell 8.81% to $2.9 after its Q4 earnings report.
The decrease in GLYC's stock price following its Q4 earnings report suggests a negative market reaction, possibly due to disappointing financial results or outlook.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Strata Skin Sciences experienced a 12.5% decrease to $0.39, following its Q4 earnings release.
The decline in SSKN's stock price post-Q4 earnings suggests the market's negative reaction to the financial results, potentially indicating concerns over the company's performance.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Avalo Therapeutics shares surged 215.8% to $15.0, significantly impacting its market valuation.
The dramatic increase in AVTX's stock price likely reflects investor optimism or a positive reaction to company-specific news, potentially leading to increased short-term trading volume and interest.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Biora Therapeutics rose 5.12% to $1.23, following its Q4 earnings report.
BIOR's stock price increase post-Q4 earnings indicates a positive market reaction, possibly due to better-than-expected financial results or future growth prospects.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 90